Trials / Completed
CompletedNCT01568320
Zenith® Dissection Clinical Trial
Use of the Zenith® Dissection Endovascular System in the Treatment of Patients With Acute, Complicated Type B Aortic Dissection
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 73 (actual)
- Sponsor
- Cook Research Incorporated · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Zenith® Dissection Clinical Trial is a clinical trial approved by US FDA to study the safety and effectiveness of the Zenith® Dissection Endovascular System in the treatment of acute, complicate Type B aortic dissection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Endovascular Treatment (Zenith) | Instead of making a large incision in the chest, the physician makes a small incision near each hip to insert, and guides the study device(s) into place in the aorta. |
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2015-02-01
- Completion
- 2020-01-27
- First posted
- 2012-04-02
- Last updated
- 2021-03-16
- Results posted
- 2021-02-16
Locations
24 sites across 2 countries: United States, Japan
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT01568320. Inclusion in this directory is not an endorsement.